Literature DB >> 23714080

Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy.

Ragesh Panikkath1, Kyndaron Reinier, Audrey Uy-Evanado, Carmen Teodorescu, Karen Gunson, Jonathan Jui, Sumeet S Chugh.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) has been associated with increased risk of sudden cardiac death (SCD), and improvements in risk stratification methodology are warranted.
METHODS: We evaluated electrocardiographic intervals as potential markers of SCD risk in LVH. Corrected QT, QRS, and JT intervals were evaluated in consecutive cases with SCD and LVH from the ongoing Oregon Sudden Unexpected Death study who underwent a 12-lead electrocardiogram (EKG) and echocardiogram prior to and unrelated to the SCD event. Comparisons of age, gender, body mass index, LV ejection fraction, and EKG intervals together with clinical conditions (hypertension and diabetes) were conducted with geographically matched controls that had coronary artery disease but no history of ventricular arrhythmias or cardiac arrest. LVH was determined using the modified American Society of Echocardiography equation for LV mass. Independent samples t-test, Pearson's chi-square test, and multiple logistic regression were used for statistical comparisons.
RESULTS: Of the 109 cases and 49 controls who met study criteria, age, gender, and comorbidities were similar among cases and controls. The mean LV mass index was not significantly different in cases compared to controls. However mean QTc (470.6 ± 53.6 ms vs 440.7 ± 38.7 ms; P < 0.0001) and QRS duration (113.6 ± 30.0 ms vs 104.9 ± 18.7 ms; P = 0.03) were significantly higher in cases than controls. In logistic regression analysis, prolonged QTc was the only EKG interval significantly associated with SCD (OR 1.72 [1.23-2.40]).
CONCLUSION: Prolonged QTc was independently associated with SCD among subjects with LVH and merits further evaluation as a predictor of SCD in LVH. ©2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23714080      PMCID: PMC3671480          DOI: 10.1111/anec.12003

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  29 in total

1.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

2.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

3.  Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction.

Authors:  L Oikarinen; M S Nieminen; M Viitasalo; L Toivonen; K Wachtell; V Papademetriou; S Jern; B Dahlöf; R B Devereux; P M Okin
Journal:  J Hypertens       Date:  2001-10       Impact factor: 4.844

Review 4.  Arrhythmogenic mechanisms in left ventricular hypertrophy.

Authors:  R Wolk
Journal:  Europace       Date:  2000-07       Impact factor: 5.214

5.  Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status.

Authors:  A Schatzkin; L A Cupples; T Heeren; S Morelock; W B Kannel
Journal:  Am J Epidemiol       Date:  1984-12       Impact factor: 4.897

6.  Standardization of M-mode echocardiographic left ventricular anatomic measurements.

Authors:  R B Devereux; E M Lutas; P N Casale; P Kligfield; R R Eisenberg; I W Hammond; D H Miller; G Reis; M H Alderman; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1984-12       Impact factor: 24.094

7.  The electrocardiogram in prediction of sudden death: Framingham Study experience.

Authors:  B E Kreger; L A Cupples; W B Kannel
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

8.  The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion.

Authors:  M C Hindman; G S Wagner; M JaRo; J M Atkins; M M Scheinman; R W DeSanctis; A H Hutter; L Yeatman; M Rubenfire; C Pujura; M Rubin; J J Morris
Journal:  Circulation       Date:  1978-10       Impact factor: 29.690

9.  Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community.

Authors:  Sumeet S Chugh; Jonathan Jui; Karen Gunson; Eric C Stecker; Benjamin T John; Barbara Thompson; Nasreen Ilias; Catherine Vickers; Vivek Dogra; Mohamud Daya; Jack Kron; Zhi-Jie Zheng; George Mensah; John McAnulty
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

10.  QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.

Authors:  Lasse Oikarinen; Markku S Nieminen; Matti Viitasalo; Lauri Toivonen; Sverker Jern; Björn Dahlöf; Richard B Devereux; Peter M Okin
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190

View more
  11 in total

1.  Fosinopril improves the electrophysiological characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive rats.

Authors:  Zhi-Bin Huang; Chun-Yu Deng; Mao-Huan Lin; Gui-Yi Yuan; Wei Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-27       Impact factor: 3.000

2.  Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.

Authors:  Elsayed Z Soliman; Amit J Shah; Andrew Boerkircher; Yabing Li; Pentti M Rautaharju
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-04-24

Review 3.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

4.  Hemodiafiltration beneficially affects QT interval duration and dispersion compared to hemodialysis.

Authors:  Kitti Barta; Árpád Czifra; Csaba Kun; Alida Páll; Julianna Kulcsár; György Paragh; István Lőrincz; Tamás János Padra; Anupam Agarwal; Abolfazl Zarjou; Zarjou Abolfazl; József Balla; Zoltán Szabó
Journal:  Clin Exp Nephrol       Date:  2014-03-04       Impact factor: 2.801

5.  Risk of Mortality Associated With QT and JT Intervals at Different Levels of QRS Duration (from the Third National Health and Nutrition Examination Survey).

Authors:  Muhammad A Zulqarnain; Waqas T Qureshi; Wesley T O'Neal; Amit J Shah; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2015-04-06       Impact factor: 2.778

6.  Effect of continuous positive airway pressure therapy on circadian patterns of cardiac repolarization in patients with obstructive sleep apnoea: data from a randomized trial.

Authors:  Christian Schlatzer; Daniel J Bratton; Esther I Schwarz; Thomas Gaisl; Justin C T Pepperell; John R Stradling; Malcolm Kohler
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

7.  Impact of Pheochromocytoma on Left Ventricular Hypertrophy and QTc Prolongation: Comparison with Takotsubo Cardiomyopathy.

Authors:  Seon Yoon Choi; Kyoung Im Cho; You Jin Han; Ga In You; Je Hun Kim; Jeong Ho Heo; Hyun Soo Kim; Tae Joon Cha; Jae Woo Lee
Journal:  Korean Circ J       Date:  2014-03-12       Impact factor: 3.243

8.  Subclinical ventricular repolarization abnormality in uncontrolled compared with controlled treated hypertension.

Authors:  Marwan S M Al-Nimer; Ismail I Hussein
Journal:  Indian Heart J       Date:  2016-08-04

9.  Influence of left ventricular type on QT interval in hypertensive patients.

Authors:  Ragesh Panikkath; Deepa Panikkath
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

10.  Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis.

Authors:  Seung Hoan Choi; Sean J Jurgens; Christopher M Haggerty; Amelia W Hall; Jennifer L Halford; Valerie N Morrill; Lu-Chen Weng; Braxton Lagerman; Tooraj Mirshahi; Mary Pettinger; Xiuqing Guo; Henry J Lin; Alvaro Alonso; Elsayed Z Soliman; Jelena Kornej; Honghuang Lin; Arden Moscati; Girish N Nadkarni; Jennifer A Brody; Kerri L Wiggins; Brian E Cade; Jiwon Lee; Christina Austin-Tse; Tom Blackwell; Mark D Chaffin; Christina J-Y Lee; Heidi L Rehm; Carolina Roselli; Susan Redline; Braxton D Mitchell; Nona Sotoodehnia; Bruce M Psaty; Susan R Heckbert; Ruth J F Loos; Ramachandran S Vasan; Emelia J Benjamin; Adolfo Correa; Eric Boerwinkle; Dan E Arking; Jerome I Rotter; Stephen S Rich; Eric A Whitsel; Marco Perez; Charles Kooperberg; Brandon K Fornwalt; Kathryn L Lunetta; Patrick T Ellinor; Steven A Lubitz
Journal:  Circ Genom Precis Med       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.